Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-08

Clinical Trial Update: Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether combining amlodipine besylate with benazepril is more effective than amlodipine alone for severe hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOTREL (amlodipine besylate and benazepril hydrochloride)
  • NORVASC (amlodipine besylate)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 4 | Status: COMPLETED